Clinical Trials in Taiwan / NCT07411703
Enrolling by invitation Observational

Automated Trainer-Based Gait Rehabilitation for Hemiplegic Stroke Patients

NCT07411703 · tracked via the Priya Life Science Taiwan tracker
Phase
Observational
Started
2025-03-26
Last updated
2026-02-17

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

NDT Gait Training System

NDT Gait Training System: The intervention consists of an NDT gait training device that replicates therapist-applied techniques through mechanical assistance, combined with synchronized auditory feedback and real-time gait analysis using IMU sensors.

Study summary

This study aims to evaluate the effectiveness of an automated mobile gait training device developed based on neurodevelopmental treatment (NDT) principles for patients with hemiplegic stroke. Stroke is a major cause of long-term disability, and many survivors experience impaired walking ability that affects their independence and daily functioning. NDT is a commonly used rehabilitation approach that emphasizes therapist-guided facilitation of normal movement patterns during gait training. However, conventional NDT gait training is physically demanding and time-consuming for therapists, which may limit the amount of repetitive gait practice patients can receive.

To address these limitations, this study introduces a power-assisted gait training device capable of reproducing key therapeutic interventions typically provided by therapists. The system uses synchronized dynamic assistance, auditory cues, and wearable inertial measurement units (IMUs) to support gait training on the ground and facilitate more natural and repetitive walking practice. The IMUs provide objective gait data that are used to evaluate changes in swing-phase symmetry, pelvic rotation amplitude, and walking speed.

The primary goal of this study is to assess changes in these gait parameters following training with the proposed NDT-based assistive device. The study plans to enroll 60 adult stroke survivors (aged 20 and older) over a 3-year period starting from March 26, 2025.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 20 years, first-ever stroke, with Brunnstrom stage III to IV of the affected lower limb motor recovery. * Functional Ambulation Category (FAC) level IV. * Ability to ambulate on level ground without assistive devices. * Ability to understand instructions and cooperate with assessments. Exclusion Criteria: * Presence of severe spinal cord injury or peripheral neuropathy. * Unstable gait requiring assistive devices, or participants at high risk of falling. * Severe impairment in vision, hearing, or cognition, making them unable to comply with assessments. * Lower limb fracture within the past 6 months.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cheng Hsin General Hospital Taipei Taiwan

More Cheng-Hsin General Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07411703 on ClinicalTrials.gov ↗ ← All trials in Taiwan